Scotiabank Lifts Merck (MRK) Target as Execution Continues to Impress

Merck & Co., Inc. (NYSE:MRK) is included among the 15 Best Wide Moat Dividend Stocks to Invest in. Scotiabank Lifts Merck (MRK) Target as Execution Continues to Impress Photo by Dan Dennis on Unsplash On February 4, Scotiabank raised its price target on Merck & Co., Inc. (NYSE:MRK) to $136 from $120 and maintained an Outperform rating. The firm said the higher target reflects multiple expansion, noting that Merck’s execution continues to run ahead of its expectations. That upgrade came shortly after M ...